AlphaCrest Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,079
| Closed | -$327K | – | 242 |
|
|
2022
Q3 | $327K | Sell |
4,079
-9
| -0.2% | -$722 | 0.02% | 1120 |
|
|
2022
Q2 | $391K | Buy |
4,088
+1,778
| +77% | +$170K | 0.02% | 1030 |
|
|
2022
Q1 | $343K | Buy |
+2,310
| New | +$343K | 0.02% | 1063 |
|
|
2021
Q4 | – | Sell |
-1,672
| Closed | -$219K | – | 1374 |
|
|
2021
Q3 | $219K | Buy |
+1,672
| New | +$219K | 0.01% | 1196 |
|
|
2020
Q3 | – | Sell |
-3,643
| Closed | -$262K | – | 1100 |
|
|
2020
Q2 | $262K | Sell |
3,643
-5,043
| -58% | -$363K | 0.04% | 692 |
|
|
2020
Q1 | $497K | Buy |
8,686
+3,361
| +63% | +$192K | 0.06% | 573 |
|
|
2019
Q4 | $595K | Buy |
+5,325
| New | +$595K | 0.05% | 671 |
|
|
2019
Q3 | – | Sell |
-8,500
| Closed | -$727K | – | 1258 |
|
|
2019
Q2 | $727K | Buy |
+8,500
| New | +$727K | 0.06% | 544 |
|